Marie A. Cucci

Turin, 10125, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Balancing the Cellular Inflammatory-Homeostatic Axis Through Natural Ingredient Supplementation.

Balancing the Cellular Inflammatory-Homeostatic Axis Through Natural Ingredient Supplementation.

Journal: Nutrients

Published: June 26, 2025

Nrf2 as a Therapeutic Target in the Resistance to Targeted Therapies in Melanoma.

Nrf2 as a Therapeutic Target in the Resistance to Targeted Therapies in Melanoma.

Journal: Antioxidants (Basel, Switzerland)

Published: May 25, 2023

Surface Functionalised Parenteral Nanoemulsions for Active and Homotypic Targeting to Melanoma.

Surface Functionalised Parenteral Nanoemulsions for Active and Homotypic Targeting to Melanoma.

Journal: Pharmaceutics

Published: February 24, 2023

Microbiota, Oxidative Stress, and Skin Cancer: An Unexpected Triangle.

Microbiota, Oxidative Stress, and Skin Cancer: An Unexpected Triangle.

Journal: Antioxidants (Basel, Switzerland)

Published: December 29, 2022

Ultrasound-Responsive Nrf2-Targeting siRNA-Loaded Nanobubbles for Enhancing the Treatment of Melanoma.

Ultrasound-Responsive Nrf2-Targeting siRNA-Loaded Nanobubbles for Enhancing the Treatment of Melanoma.

Journal: Pharmaceutics

Published: December 25, 2021

Oxidative Stress-Related Mechanisms in Melanoma and in the Acquired Resistance to Targeted Therapies.

Oxidative Stress-Related Mechanisms in Melanoma and in the Acquired Resistance to Targeted Therapies.

Journal: Antioxidants (Basel, Switzerland)

Published: October 31, 2021

Post-translational down-regulation of Nrf2 and YAP proteins, by targeting deubiquitinases, reduces growth and chemoresistance in pancreatic cancer cells.

Post-translational down-regulation of Nrf2 and YAP proteins, by targeting deubiquitinases, reduces growth and chemoresistance in pancreatic cancer cells.

Journal: Free radical biology & medicine

Published: June 17, 2021

Control of Oxidative Stress in Cancer Chemoresistance: Spotlight on Nrf2 Role.

Control of Oxidative Stress in Cancer Chemoresistance: Spotlight on Nrf2 Role.

Journal: Antioxidants (Basel, Switzerland)

Published: February 25, 2021

Carbosilane Dendrimers Loaded with siRNA Targeting Nrf2 as a Tool to Overcome Cisplatin Chemoresistance in Bladder Cancer Cells.

Carbosilane Dendrimers Loaded with siRNA Targeting Nrf2 as a Tool to Overcome Cisplatin Chemoresistance in Bladder Cancer Cells.

Journal: Antioxidants (Basel, Switzerland)

Published: September 25, 2020

Ailanthone increases oxidative stress in CDDP-resistant ovarian and bladder cancer cells by inhibiting of Nrf2 and YAP expression through a post-translational mechanism.

Ailanthone increases oxidative stress in CDDP-resistant ovarian and bladder cancer cells by inhibiting of Nrf2 and YAP expression through a post-translational mechanism.

Journal: Free radical biology & medicine

Published: January 08, 2020

Glutathione-responsive cyclodextrin-nanosponges as drug delivery systems for doxorubicin: Evaluation of toxicity and transport mechanisms in the liver.

Glutathione-responsive cyclodextrin-nanosponges as drug delivery systems for doxorubicin: Evaluation of toxicity and transport mechanisms in the liver.

Journal: Toxicology in vitro : an international journal published in association with BIBRA

Published: November 21, 2019

Novel tetrahydroacridine derivatives with iodobenzoic moieties induce G0/G1 cell cycle arrest and apoptosis in A549 non-small lung cancer and HT-29 colorectal cancer cells.

Novel tetrahydroacridine derivatives with iodobenzoic moieties induce G0/G1 cell cycle arrest and apoptosis in A549 non-small lung cancer and HT-29 colorectal cancer cells.

Journal: Molecular and cellular biochemistry

Published: January 20, 2019

Showing 1-12 of 15

Last Updated: 09/26/2026